Eligibility for mepolizumab, omalizumab and reslizumab in the EU population: The IDEAL study Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016
Multivariate cluster analysis of immunopathological and clinical data from the U-BIOPRED severe asthma study: Preliminary results Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015
Evaluation of roflumilast in COPD patients in a real-world European setting: results from the PROFILE EU study Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies? Year: 2017
Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021
Interim analysis of a prospective study investigating oral corticosteroid (OCS) use in omalizumab treated severe allergic asthma patients: APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014
Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
An Italian, observational, multicentre trial to describe treatment management in COPD patients: Preliminary results of the MISTRAL study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
Preliminary results from the laboratory phase of ECRHSIII in Melbourne Source: Annual Congress 2013 –Epidemiology of asthma Year: 2013
Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Asthma exacerbations with long-term follow-up: a retrospective study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019
The EDUCA (Elderly and Device Use in Chronic Asthma) multicentre Italian study on the assessment of errors and satisfaction in using the inhalers in elderly asthmatics: Preliminary results. Source: International Congress 2017 – Inhalers and their use Year: 2017
Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis Source: Eur Respir J, 56 (4) 2000151; 10.1183/13993003.00151-2020 Year: 2020
An Italian, observational, multicenter trial in female COPD patients: Preliminary data on the women reality in the MISTRAL study Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014
The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
Patient burden of not well-controlled asthma: results of a European survey Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009
Attention to ACOS in patients with asthma and COPD:Results from a national- multicentered study Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017
Stop omalizumab: a multicenter follow up study after discontinuation in pediatric patients with severe asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021
Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study Source: ERJ Open Res, 7 (3) 00004-2021; 10.1183/23120541.00004-2021 Year: 2021
Patients in randomized clinical trials of bronchiectasis are only partially representative of clinical practice: A European cohort study Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015